Institutional Cluster

CLDX

Celldex Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed3mo ago
Institutional cluster: 2 buyers, 3 sellers (mixed)
Actionable Insight • Neutral

The cluster is entirely passive — no active manager signal. The selling by Morgan Stanley and UBS may reflect index rebalancing or risk-management adjustments, not a negative thesis. Monitor next 13F for active-manager entries or exits; the lack of activist/hedge-fund interest keeps the stock in a wait-and-see posture.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+20d ⚠ clustered
CLDX ▲ +30.11% at T+20d
NEUTRAL call ✓ call won +30.11% · α vs SPY +28.22% · entry $29.96 → $38.98
Next anchor: T+60d due 24d ago
Latest observation: T+58 +40.66% FF3 residual α
Entry anchored
Jun 10, 03:59 PM ET
via exchange tick
T+1d
+4.37%
call +4.37% · α +3.83%
$31.27
settled 4mo ago
T+5d
+9.91%
call +9.91% · α +9.48%
$32.93
settled 4mo ago
T+20d
+30.11%
call +30.11% · α +28.22%
$38.98
settled 3mo ago
T+60d
—
call — · α —
—
due 24d ago

Executive Summary

A mixed institutional cluster in CLDX for Q3 2025 shows two mega-passive buyers (Wells Fargo, Invesco) adding modest positions totaling $1.6M, while three mega-passive sellers (Morgan Stanley, UBS, T. Rowe Price) trimmed $11.8M in holdings. The net selling pressure of ~$10.2M from passive rebalancing is notable but lacks active-manager conviction, suggesting routine portfolio adjustments rather than a fundamental thesis.

Key Financial Metrics

Direction
distributing
Buy Value
$3.8M
Sell Value
$11.8M
Net Flow
-$10.2M

Institutional Positions

Net institutional flow: -$10.2M

▲ Buyers (2)

InstitutionActionChangePosition ValueValue Δ
Wells FargoADD+56.6%$1.8M$872.0K
InvescoADD+25.4%$2.0M$761.0K

▼ Sellers (3)

InstitutionActionChangePrev ValueValue Δ
Morgan StanleyTRIM-52.8%$13.5M-$5.4M
UBSTRIM-50.5%$17.1M-$6.3M
T. Rowe PriceTRIM-37.6%$78.0K-$16.1K

Key Facts

  • 2 buyers added $1.6M in new holdings; 3 sellers reduced $11.8M
  • All five institutions are mega-passive (index/quant) — no active managers or hedge funds involved
  • Largest seller: UBS trimmed $6.3M (-50.5% of position); Morgan Stanley cut $5.4M (-52.8%)
  • Net aggregate change: -$10.2M, dominated by passive rebalancing
  • Historical reports on CLDX show 70% win rate at T+20 but negative alpha vs SPY (-5.21%)

Financial Impact

Net institutional selling of approximately $10.2M, with total selling value of $11.8M versus buying of $1.6M

institutional ownershipfloat

Risk Factors

  • Passive selling could continue if CLDX is underweighted in indices
  • No active-manager buying suggests limited catalyst-driven demand
  • Historical alpha vs SPY is negative (-5.21% T+20), indicating stock underperforms market on these signals

Market Snapshot

Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
91% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-CLDX-2025-Q3
13 reports for CLDX
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+20▲ +19.96%Jun 14, 2026
Filters
Rows
Reports for CLDX — sortable, filterable
TypeNow
Jun 14, 2026
15w ago
Press Release
BEARISH ★ 6/10
$32.12 $38.53▼ −19.96%▼ −20.71%—
Jun 14, 2026
15w ago
Press Release
BULLISH ★ 7/10
$32.12 $38.53▲ +19.96%▲ +20.71%—
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 4/10
$29.96 $38.98▲ +30.11%▲ +28.22%—
Jun 10, 2026
16w ago
Press Release
NEUTRAL ★ 4/10
$29.96 $38.98▲ +30.11%▲ +28.22%—
May 7, 2026
21w ago
8-K
MIXED ★ 6/10
$33.97 $28.62▼ −15.75%▼ −15.77%—
May 7, 2026
21w ago
Press Release
MIXED ★ 6/10
$33.97 $28.62▼ −15.75%▼ −15.77%—
Apr 6, 2026
25w ago
Press Release
NEUTRAL ★ 5/10
$31.37 $32.77▲ +4.46%▼ −4.52%—
Apr 2, 2026
26w ago
Press Release
NEUTRAL ★ 5/10
$31.06 $32.88▲ +5.86%▼ −4.02%—
Apr 1, 2026
26w ago
424B5
NEUTRAL ★ 5/10
$31.06 $32.88▲ +5.86%▼ −4.02%—
Apr 1, 2026
26w ago
Press Release
NEUTRAL ★ 4/10
$31.06 $32.88▲ +5.86%▼ −4.02%—
Showing 10 of 13

US Market Status

Market Open — Closes in 2h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026